(112 days)
Not Found
No
The 510(k) summary describes a traditional hip implant system and its components, with no mention of AI or ML technology in the intended use, device description, or performance studies.
Yes
The device, a total hip arthroplasty system, is used to treat various painful and debilitating hip conditions, aiming to alleviate symptoms and improve physical function.
No
The device is a total hip arthroplasty system, comprised of various components like femoral stems, heads, acetabular shells, and inserts, intended for surgical implantation to treat hip conditions. It does not perform diagnostic functions such as identifying or analyzing disease.
No
The device description explicitly lists hardware components (femoral stems, femoral heads, acetabular shells, acetabular inserts, bone screws) made of various materials, indicating it is a physical implant system, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, or tissue) to provide information about a person's health.
- Device Description: The provided text describes components of a total hip arthroplasty system. These are implantable devices used to replace a damaged hip joint.
- Intended Use: The intended use clearly states the device is for total hip arthroplasty to treat various hip conditions. This involves surgical implantation, not laboratory testing of samples.
The description focuses on the materials, components, and surgical application of the device, which are characteristic of an implantable medical device, not an IVD.
N/A
Intended Use / Indications for Use
The Cardo Medical Hip System components are for use in total hip arthroplasty as a result of:
- . Hip arthritis caused by rheumatoid disease, non-inflammatory degenerative joint disease, osteoarthritis, and arthritis resulting from biologic or mechanical trauma to the hip
- . Correction of functional deformity
- Avascular Necrosis .
- Treatment of non-unions, femoral neck and trochanteric fractures of the proximal femur .
- Difficult clinical management problems involving persistent pain and physical impairment where . conventional arthodesis is not likely to achieve satisfactory results
These components are single use only and are intended for implantation without bone cement.
Product codes
LPH, HWC
Device Description
The previously cleared Cardo Medical Hip System consists of:
• commercially pure titanium plasma spray-coated titanium alloy (Ti-6Al-4V) femoral stems,
• cobalt chrome (CoCr) femoral heads
• commercially pure titanium plasma spray-coated titanium alloy (Ti-6Al-4V) acetabular shells
• ultra-high molecular weight polyethylene (UHMWPE) acetabular inserts and
• titanium alloy (Ti-6Al-4V) bone screws.
The proposed devices are a line extension to the previously cleared system to add 36mm femoral heads and 36mm inserts.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
This 510(k) is for the addition of 36mm femoral heads and inserts. These heads and inserts do not present a worst case loading condition on the components (the 28mm femoral head component with the +12mm offset); therefore the previous testing applies to these components.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3358 Hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis.
(a)
Identification. A hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across the joint. This generic type of device has a femoral component made of a cobalt-chromium-molybdenum (Co-Cr-Mo) alloy or a titanium-aluminum-vanadium (Ti-6Al-4V) alloy and an acetabular component composed of an ultra-high molecular weight polyethylene articulating bearing surface fixed in a metal shell made of Co-Cr-Mo or Ti-6Al-4V. The femoral stem and acetabular shell have a porous coating made of, in the case of Co-Cr-Mo substrates, beads of the same alloy, and in the case of Ti-6Al-4V substrates, fibers of commercially pure titanium or Ti-6Al-4V alloy. The porous coating has a volume porosity between 30 and 70 percent, an average pore size between 100 and 1,000 microns, interconnecting porosity, and a porous coating thickness between 500 and 1,500 microns. The generic type of device has a design to achieve biological fixation to bone without the use of bone cement.(b)
Classification. Class II.
0
Cardo Medical Hip Components Premarket Notification Submission - 510(k)
:
- •
094045
Page 1 of 2
510(k)_Summary of Safety and Effectiveness
| Submitter: | Michael Kvitnitsky
Cardo Medical, Inc.
10 Clifton Blvd., Suite B1
Clifton, NJ 07011
Tel: 973-777-8832, ext. 302
Fax: 973-777-8851 | APR 22 2010 |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------|
| Date Prepared: | April 12, 2010 | |
| Device: | Cardo Medical Hip System | |
| Classification: | 87 LPH and 87 HWC - Hip joint metal/polymer/metal semi-constrained
uncemented prosthesis, 21 CFR 888.3358 Class II | |
| Predicate Devices: | Accin™ Hip System (now Cardo Medical Hip System) - K073068
Exactech 12/14 Total Hip System (Exactech, Inc.) - K041906, K993082 | |
| Device Description: | The previously cleared Cardo Medical Hip System consists of:
• commercially pure titanium plasma spray-coated titanium alloy (Ti-6Al-4V) femoral stems,
• cobalt chrome (CoCr) femoral heads
• commercially pure titanium plasma spray-coated titanium alloy (Ti-6Al-4V) acetabular shells
• ultra-high molecular weight polyethylene (UHMWPE) acetabular inserts and
• titanium alloy (Ti-6Al-4V) bone screws.
The proposed devices are a line extension to the previously cleared system to add 36mm femoral heads and 36mm inserts. | |
| Intended Use: | The Cardo Medical Hip System components are for use in total hip arthroplasty as a result of:
• Hip arthritis caused by rheumatoid disease, non-inflammatory degenerative joint disease, osteoarthritis, and arthritis resulting from biologic or mechanical trauma to the hip
• Correction of functional deformity
• Avascular Necrosis
• Treatment of non-unions, femoral neck and trochanteric fractures of the proximal femur
• Difficult clinical management problems involving persistent pain and physical impairment where conventional arthodesis is not likely to achieve satisfactory results
These components are single use only and are intended for implantation without bone cement. | |
1
Comparison to Predicates:
The proposed devices are a line extension to add 36mm femoral heads and inserts.
Femoral Stems
r enoral stems
There has been no change to the existing femoral stems, available in 21 sizes from 6mm to 22.5mm with a regular or lateral offset. The stems are gamma irradiated.
Femoral Heads
The proposed 36mm cobalt chrome femoral heads have the same 12/14 trunnion taper as the previously The proposal ounline oblines to the les 22, 26, 28 and 32 mm OD in a variety of offsets (K073068). The 36mm femoral head will have offsets of -5, -3.5, 0, +3.5 and +5mm. The prior offsets ranged from -3.5 to +12mm with the +12mm being the worst case. The heads are gamma sterilized.
The proposed 36mm heads are equivalent to the Accin Hip System (K073068) in materials, design, packaging, and sterilization and equivalent to the Exactech 12/14 total hip system femoral heads in size.
Acetabular Shells
There has been no change to the existing acetabular shells. They are designed to mate with the acetabular inserts with a permanently inserted retaining ring and have three clustered holes for bone screws, if necessary. Each shell has a size that matches it to the correct inserts and are gamma sterilized.
Acetabular Inserts
Accrabular Moorts inserts (K073068). The prior inserts are offered in standard and 10° hooded variations. The proposed insorts (not over, "The prior inserts are available in 22mm, 26mm, 26mm, 26mm, and 32mm inner diameter sizes. They are designed to mate with the previously cleared acetabular shells. Each liner has a size designation that metches it to the correct mating shell component. The new 36mm acetabular liners are designed to articulate with the proposed 36mm Cardo Medical coball chrome femoral heads. The inserts are gamma sterilized.
The proposed 36mm inserts are equivalent to the Accin Hip System (K073068) in materials, design, r no proposod ountil into to and equivalent to the Exactech 12/14 total hip system inserts in ID and OD.
Bone Screws
There has been no change to the existing titanium alloy bone screws cleared in K073068, which are in a There has boon no enange to are extram 15mm to 60mm. The screws are gamma sterilized.
Summary
Summary
Cardo Medical, Inc. has determined that any differences in the proposed device will not impact the safety or effectiveness of the hip system for its intended use. Testing has shown that the proposed device or encourtiness of the hip typestify to the numents on total hip arthroplasty product and the proposed device is equivalent to the predicate device.
All Cardo medical implant components are provided as sterile, single use only to a sterility assurance level (SAL) of 10°.
Synopsis of Test Methods and Results:
This 510(k) is for the addition of 36mm femoral heads and inserts. These heads and inserts do not r his STO(K) is for the duallion of commiss ( the 28mm femoral head component with the +12mm offset); therefore the previous testing applies to these components.
2
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with three lines representing its wings.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
APR 2 2 2010
Cardo Medical, Inc. % Mr. Mike Kvitnitsky Chief Operating Officer and President 10 Clifton Boulevard, Suite Bl Clifton, New jersey 07011
Re: K094045
Trade/Device Name: Cardo Medical Hip System Regulation Number: 21 CFR 888.3358 Regulation Name: Hip Joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis Regulatory Class: II Product Code: LPH, HWC Dated: February 11, 2010 Received: February 16, 2010
Dear Mr. Kvitnitsky:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
3
Page 2- Mr. Mike Kvitnitsky
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Director Division of Surgical, Orthopedic, and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use Form
94047 510(k) Number (if known):
Device Name: Cardo Medical Hip System
Indications for Use:
The Cardo Medical Hip System components are for use in total hip arthroplasty as a result of:
-
. Hip arthritis caused by rheumatoid disease, non-inflammatory degenerative joint disease, osteoarthritis, and arthritis resulting from biologic or mechanical trauma to the hip
-
. Correction of functional deformity
-
Avascular Necrosis .
-
Treatment of non-unions, femoral neck and trochanteric fractures of the proximal femur .
-
Difficult clinical management problems involving persistent pain and physical impairment where . conventional arthodesis is not likely to achieve satisfactory results
These components are single use only and are intended for implantation without bone cement.
Prescription Use × (Per 21 CFR 801.109)
OR
Over-The-Counter Use (Optional Format 1-2-96)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Sputa for mkn
Page 1 of 1
(Diffision Sign Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K094045